180 related articles for article (PubMed ID: 2171449)
1. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
Nutt DJ; Glue P; Lawson C; Wilson S
Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
[TBL] [Abstract][Full Text] [Related]
2. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.
Woods SW; Charney DS; Silver JM; Krystal JH; Heninger GR
Psychiatry Res; 1991 Feb; 36(2):115-27. PubMed ID: 1850142
[TBL] [Abstract][Full Text] [Related]
3. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
Ströhle A; Kellner M; Holsboer F; Wiedemann K
Biol Psychiatry; 1999 Feb; 45(3):321-6. PubMed ID: 10023509
[TBL] [Abstract][Full Text] [Related]
4. Effect of flumazenil in lactate-sensitive patients with panic disorder.
Ströhle A; Kellner M; Yassouridis A; Holsboer F; Wiedemann K
Am J Psychiatry; 1998 May; 155(5):610-2. PubMed ID: 9585710
[TBL] [Abstract][Full Text] [Related]
5. Effects of the benzodiazepine antagonist flumazenil in PTSD.
Randall PK; Bremner JD; Krystal JH; Nagy LM; Heninger GR; Nicolaou AL; Charney DS
Biol Psychiatry; 1995 Sep; 38(5):319-24. PubMed ID: 7495926
[TBL] [Abstract][Full Text] [Related]
6. Flumazenil challenge in social phobia.
Coupland NJ; Bell C; Potokar JP; Dorkins E; Nutt DJ
Depress Anxiety; 2000; 11(1):27-30. PubMed ID: 10723632
[TBL] [Abstract][Full Text] [Related]
7. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D
Alcohol Alcohol; 1997; 32(5):605-11. PubMed ID: 9373703
[TBL] [Abstract][Full Text] [Related]
8. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users.
Bernik MA; Gorenstein C; Vieira Filho AH
J Psychopharmacol; 1998; 12(2):146-50. PubMed ID: 9694026
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders.
Schönhofer B; Köhler D
Eur Respir J; 1996 Sep; 9(9):1816-20. PubMed ID: 8880096
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
11. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.
Bradwejn J; Koszycki D; Couëtoux du Tertre A; Paradis M; Bourin M
Psychopharmacology (Berl); 1994 Mar; 114(2):257-61. PubMed ID: 7838917
[TBL] [Abstract][Full Text] [Related]
12. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties.
Sliva J; Hess L; Votava M; Malek J
Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
14. [The benzodiazepine receptor: the enigma of the endogenous ligand].
Pélissolo A
Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
[TBL] [Abstract][Full Text] [Related]
15. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.
Baldwin HA; File SE
Brain Res Bull; 1988 May; 20(5):603-6. PubMed ID: 2838131
[TBL] [Abstract][Full Text] [Related]
16. Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder.
Bell C; Hood S; Potokar J; Nash J; Adrover M; Frampton C; Hince D; Rich A; Argyropoulos S; Nutt D
Psychopharmacology (Berl); 2011 Feb; 213(2-3):593-602. PubMed ID: 19823804
[TBL] [Abstract][Full Text] [Related]
17. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
Cameron OG; Huang GC; Nichols T; Koeppe RA; Minoshima S; Rose D; Frey KA
Arch Gen Psychiatry; 2007 Jul; 64(7):793-800. PubMed ID: 17606813
[TBL] [Abstract][Full Text] [Related]
18. Role of gamma-aminobutyric acid in antipanic drug efficacy.
Breslow MF; Fankhauser MP; Potter RL; Meredith KE; Misiaszek J; Hope DG
Am J Psychiatry; 1989 Mar; 146(3):353-6. PubMed ID: 2537582
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients.
Woods SW; Charney DS; Delgado PL; Heninger GR
J Clin Psychiatry; 1990 Dec; 51(12):505-7. PubMed ID: 2175307
[TBL] [Abstract][Full Text] [Related]
20. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
Wiedemann K; Jahn H; Yassouridis A; Kellner M
Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
